We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is a Cystosarcoma Phyllode?

By Clara Kedrek
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A rare breast tumor most commonly seen in middle-aged women, a cystosarcoma phyllode is a growth that arises from the cells making up the tissue of the breast. Although most often these tumors are benign, sometimes they do have the ability to grow into surrounding structures and to distant parts of the body. Diagnosis of the tumor relies on taking a sample from the mass, and treatment focuses on removing the abnormal breast tissue.

A cystosarcoma phyllode tumor is thought to form in the stromal cells of the breast. These cells make up the breast tissue, and can grow and divide in response to high levels of hormones in the blood, such as estrogen or progesterone. For unknown reasons, in rare cases these stromal cells can begin to multiply in an unregulated fashion, and can even invade surrounding structures or spread to far-away regions of the body. This unregulated growth of stromal cells causes the development of the cystosarcoma phyllode tumor.

Risk factors for the development of a cystosarcoma phyllode tumor are poorly understood. The tumors typically appear in women in their forties. Often, women who develop the tumor at a later age have disease that is more difficult to treat. A rare genetic condition known as Li-Fraumeni syndrome is known to cause this type of tumor.

The definitive diagnosis of a cystosarcoma phyllode tumor relies on taking a biopsy of the mass and inspecting it under the microscope. The tumor itself might be detected by self breast exam, clinical breast exam by a licensed medical practitioner, or by mammography — a radiographic procedure used to look for abnormalities in the breast tissue. After a mass is identified, it can either be biopsied by removing a small section of the tumor, or can immediately be fully removed.

Treatment of a cystosarcoma phyllode tumor focuses on its surgical removal. Specialists in breast surgery carefully remove the tumor, making sure to remove all of the abnormal tumor tissue. Resected tissue is typically then sent to a pathologist who can review the margins to ensure that the entire tumor was removed.

The prognosis of a patient suffering from a cystosarcoma phyllode tumor depends on a number of factors. Many of these tumors are benign, meaning that by nature they do not infiltrate surrounding structures or spread to distant parts of the body. Prognosis in these patients is typically good, although they do have to be monitored for future recurrence of the disease. If the tumor is malignant, meaning that it does have the propensity to spread to different regions, achieving a cure from the disease is more difficult. These patients might require chemotherapy or radiation therapy in order to more completely eradicate the tumor.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.